MLNSX
Price
$23.55
Change
-$0.09 (-0.38%)
Updated
Nov 4 closing price
RPEBX
Price
$62.60
Change
-$0.02 (-0.03%)
Updated
Nov 4 closing price
Ad is loading...

MLNSX vs RPEBX

Header iconMLNSX vs RPEBX Comparison
Open Charts MLNSX vs RPEBXBanner chart's image
Morgan Stanley Instl Glbl Concntr R6
Price$23.55
Change-$0.09 (-0.38%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R2E
Price$62.60
Change-$0.02 (-0.03%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MLNSX vs RPEBX Comparison Chart
Loading...
VS
MLNSX vs. RPEBX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLNSX is a Buy and RPEBX is a Sell.

FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 142B vs. MLNSX (217M). MLNSX pays higher dividends than RPEBX: MLNSX (0.68) vs RPEBX (0.46). MLNSX was incepted earlier than RPEBX: MLNSX (8 years) vs RPEBX (10 years). MLNSX is a more actively managed with annual turnover of: 51.00 vs. RPEBX (17.00). RPEBX has a lower initial minimum investment than MLNSX: RPEBX (250) vs MLNSX (5000000). MLNSX annual gain was more profitable for investors over the last year : 44.36 vs. RPEBX (21.49). MLNSX return over 5 years is better than : 82.78 vs. RPEBX (38.46).
MLNSXRPEBXMLNSX / RPEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years10 years-
Gain YTD33.05115.010220%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets217M142B0%
Annual Yield % from dividends0.680.46148%
Returns for 1 year44.3621.49206%
Returns for 3 years16.12-11.74-137%
Returns for 5 years82.7838.46215%
Returns for 10 yearsN/A65.05-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATHA0.640.03
+5.61%
Athira Pharma
REX45.661.36
+3.07%
REX American Resources Corp
DNLI27.210.16
+0.59%
Denali Therapeutics
BLDR172.430.41
+0.24%
Builders FirstSource
WSBF14.72-0.02
-0.10%
Waterstone Financial